NeuroScience NorLox Ultra 60 Capsules

NeuroScience

$68.00
(No reviews yet) Write a Review
SKU:
NS0046
Condition:
New
Availability:
In Stock
Disclaimer:
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Adding to cart… The item has been added

Contains ingredients important for the management of joint aches*

Key ingredients
Boswellia serrata (70% total boswellic acids): Leukotrienes are immune mediators that induce and sustain immune activation (1). Boswellic acids are shown to inhibit 5-lipoxygenase (5-LOX), an enzyme responsible for the synthesis of immunostimulatory molecules called leukotrienes (2, 3).* In a randomized, double-blind, placebo-controlled, crossover study, Boswellia serrata significantly improved the threshold and tolerance to musculoskeletal discomfort (4).*

Curcuma longa (Turmeric) (95% curcuminoids): Botanical shown to lower levels of TNF-α and IL-6 (5).* TNF-α and IL-6 are cytokines that play an important role in regulating the immune response and joint discomfort (6, 7). Elevated levels of TNF-α and IL-6 in joint fluid have been correlated with increased joint discomfort (8, 9).

L-cysteine: Precursor to glutathione (10).* Glutathione provides antioxidant protection and detoxification properties (10).

5-HTP (from Griffonia simplicifolia seed extract): 5-hydroxytryptophan (5-HTP) crosses the blood-brain barrier and is a precursor to serotonin and melatonin (11).* Serotonin plays an important role in processing and inhibiting pain signaling by the central nervous system (12).

References

  1. Gennara A and Haeggstrom J. Adv Immunol. 2012;116:51-92.
  2. Schweizer S, et al. J Nat Prod. 2000;63:1058-61.
  3. Radmark O, et al. Biochim Biophys Acta. 2015;1851(4):331-9.
  4. Prabhavathi K, et al. Indian J Pharmacol. 2014;46(5):475-9.
  5. Usharani P, et al. Drugs R D. 2008;9(4):243-50.
  6. Holdsworth S and Gan P. Clin J Am Soc Nephrol. 2015;10(12):2243-54.
  7. Miller R, et al. Cytokine. 2014;70(2):185-93.
  8. Orita S, et al. BMC Musculoskelet Disord. 2011;12:144.
  9. Cuellar J, et al. J Bone Joint Surg Am. 2009;91(10):2313-20.
  10. Rushworth G and Megson I. Pharmacol Ther. 2014;141(2):150-9.
  11. Shaw K, et al. Cochrane Database Syst Rev. 2002;(1):CD003198.
  12. Bardin L. Behav Pharmacol. 2011;22(5-6):390-404.